24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825

Diabetes
Resources
Basic InformationLatest News
Diabetes Treatment Failure May Actually Be NonadherenceArtificial Intelligence Can Detect Diabetic RetinopathyMore Than 1 in 10 Patients May Be Overtreated for DiabetesPioglitazone Has Limited Effect in Lipoatrophic DiabetesFracture Risk Higher for Seniors With DiabetesCGM Use in Pregnancy Improves Neonatal OutcomesClosed-Loop Control Benefits T1DM in Prolonged Winter SportHeath Tip: Dining Out If You Have DiabetesExenatide Doesn't Up Cardiovascular Risk in T2DMIncreasing Salt Intake Tied to Diabetes RiskSotagliflozin Linked to Improved Glycemic Control in T1DMGreater Awareness Needed for Potential of T2DM RemissionCan Coffee or Tea Extend Survival With Diabetes?Could Artificial Sweeteners Raise Your Diabetes Risk?Could Swine Flu Be Linked to Type 1 Diabetes?'Upside' to Diabetes Really Isn'tLifestyle Tips for Better Diabetes ControlDiabetes Threatens Kidneys, Vision of Millions of Americans2017 Standards of Medical Care in Diabetes ReleasedBiomarkers Can Predict Rapid Drop in Renal Function in T2DMMany Teens With Type 1 Diabetes Report Disordered EatingCognitive Test Predicts Elderly Insulin Injection SuccessHigher Event Rate of T2DM in Polycystic Ovary SyndromeNovel Genetic Variant in IGF2 Linked to Reduced T2DM RiskFatty Acid Remodeling Seen in T2DM Remission Post Bariatric SxDiacerein Reduces Mean Hemoglobin A1c Levels in T2DMHealth Tip: Risk Factors for PrediabetesTablet Use Encourages Patients to Explore Diabetes RiskOnce-Yearly Counseling Tied to More Physical Activity in T2DMIn T2D, Glycemic Control Up With Continuous Glucose MonitoringSecure Messaging Linked to Better Diabetes ManagementStudies Often Fail to Include Info on T2DM Medication AdherenceIntensive Blood Pressure Tx Aids Those With PrediabetesLifestyle Intervention Only Offers Modest Benefit in Type 2 DiabetesSleep Duration Inversely Linked to Risk Markers of T2DM in KidsCould Big Lifestyle Changes Be Key to Managing Type 2 Diabetes?Variation in Participation in Diabetes Self-Management ClassTeam-Based Online Game May Improve Glycemic Control in T2DArtificial Sweeteners Trick the Brain: StudyCharacteristics of Diabetes in Infancy ExploredImmunotherapy Shown Safe in Type 1 Diabetes Clinical TrialOnline Game Helps Those With Diabetes Control Blood SugarHeart Health Ignored by Many With Type 2 DiabetesMortality Down Only for Gastric Bypass Patients With DiabetesInstagram Shows How Diabetics Really Wear a Glucose MonitorWhat Diabetics Need to Know About Over-the-Counter MedsEngineered Skin Cells Control Type 2 Diabetes in Mice: StudySimilar Defects ID'd for T2DM, Chronic Pancreatitis and DiabetesDiabetes Symptoms Appear to Spread Via Prion-Like MechanismPoor Adherence to Self-Monitoring of Glucose in GDM
Links
Related Topics

Medical Disorders

Predictive Low-Glucose Mgmt Cuts Hypoglycemic Events in T1D


HealthDay News
Updated: Mar 31st 2017

new article illustration

FRIDAY, March 31, 2017 (HealthDay News) -- For children with type 1 diabetes, use of the predictive low-glucose management (PLGM) feature of the MiniMed 640G system is associated with a reduced number of hypoglycemic events, according to a study published online March 28 in Diabetes Care.

Tadej Battelino, M.D., from the University Children's Hospital in Ljubljana, Slovenia, and colleagues conducted a randomized trial involving 100 children and adolescents with type 1 diabetes and glycated hemoglobin A1c ≤10 percent and using continuous subcutaneous insulin infusion. Participants were randomized in a 1:1 ratio to an intervention group with PLGM features enabled (PLGM ON) or a control group (PLGM OFF).

The researchers found that the PLGM ON group had a significantly smaller number of hypoglycemic events <65 mg/dL compared with the PLGM OFF group (mean ± standard deviation: 4.4 ± 4.5 versus 7.4 ± 6.3; P = 0.008). The finding persisted when the events were calculated separately for night and day (P = 0.025 and 0.022, respectively). There were no severe hypoglycemic events; in the PLGM ON group there was an increase in time spent >140 mg/dL (P = 0.0165).

"The PLGM insulin suspension was associated with a significantly reduced number of hypoglycemic events," the authors write. "Although this was achieved at the expense of increased time in moderate hyperglycemia, there were no serious adverse effects in young patients with type 1 diabetes."

Several authors disclosed financial ties to pharmaceutical and medical device companies, including Medtronic, which manufactures the MiniMed 640G system and funded the study.

Abstract/Full Text (subscription or payment may be required)